Stock Scorecard
Stock Summary for ABVC BioPharma Inc (ABVC) - $1.07 as of 9/16/2026 7:10:45 AM EST
Total Score
5 out of 30
Safety Score
13 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ABVC
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ABVC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ABVC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ABVC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ABVC (13 out of 100)
| Stock Price Rating (Max of 10) | 2 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ABVC
Financial Details for ABVC
Company Overview |
|
|---|---|
| Ticker | ABVC |
| Company Name | ABVC BioPharma Inc |
| Country | USA |
| Description | American BriVision (Holding) Corporation, a clinical-stage biopharmaceutical company, develops drugs and medical devices to meet unmet medical needs in the United States. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 6/30/2026 |
| Next Earnings Date | 10/30/2026 |
Stock Price History |
|
| Last Day Price | 1.07 |
| Price 4 Years Ago | 6.25 |
| Last Day Price Updated | 9/16/2026 7:10:45 AM EST |
| Last Day Volume | 285,682 |
| Average Daily Volume | 108,887 |
| 52-Week High | 3.40 |
| 52-Week Low | 0.71 |
| Last Price to 52 Week Low | 50.70% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 36.33 |
| Sector PE | 56.77 |
| 5-Year Average PE | -6.38 |
| Free Cash Flow Ratio | 0.00 |
| Industry Free Cash Flow Ratio | 34.94 |
| Sector Free Cash Flow Ratio | 39.28 |
| Current Ratio Most Recent Quarter | 0.07 |
| Total Cash Per Share | 0.00 |
| Book Value Per Share Most Recent Quarter | 0.40 |
| Price to Book Ratio | 2.55 |
| Industry Price to Book Ratio | 4.78 |
| Sector Price to Book Ratio | 23.32 |
| Price to Sales Ratio Twelve Trailing Months | 111.69 |
| Industry Price to Sales Ratio Twelve Trailing Months | 14.84 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.48 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 26,654,400 |
| Market Capitalization | 28,520,208 |
| Institutional Ownership | 4.09% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 3.56% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -61.30% |
| Reported EPS 12 Trailing Months | -0.29 |
| Reported EPS Past Year | -0.70 |
| Reported EPS Prior Year | -2.49 |
| Net Income Twelve Trailing Months | -7,902,583 |
| Net Income Past Year | -7,908,554 |
| Net Income Prior Year | -4,902,878 |
| Quarterly Revenue Growth YOY | 104.50% |
| 5-Year Revenue Growth | 10.50% |
| Operating Margin Twelve Trailing Months | 0.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 31,944 |
| Total Cash Past Year | 681,480 |
| Total Cash Prior Year | 863,815 |
| Net Cash Position Most Recent Quarter | -968,056 |
| Net Cash Position Past Year | -318,520 |
| Long Term Debt Past Year | 1,000,000 |
| Long Term Debt Prior Year | 1,569,456 |
| Total Debt Most Recent Quarter | 1,000,000 |
| Equity to Debt Ratio Past Year | 0.92 |
| Equity to Debt Ratio Most Recent Quarter | 0.91 |
| Total Stockholder Equity Past Year | 11,111,861 |
| Total Stockholder Equity Prior Year | 1,226,140 |
| Total Stockholder Equity Most Recent Quarter | 10,287,183 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -2,935,361 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.11 |
| Free Cash Flow Past Year | -2,992,090 |
| Free Cash Flow Prior Year | -1,809,150 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.02 |
| MACD Signal | -0.06 |
| 20-Day Bollinger Lower Band | 0.68 |
| 20-Day Bollinger Middle Band | 1.17 |
| 20-Day Bollinger Upper Band | 1.66 |
| Beta | 0.61 |
| RSI | 52.49 |
| 50-Day SMA | 1.75 |
| 150-Day SMA | 1.39 |
| 200-Day SMA | 2.39 |
System |
|
| Modified | 9/15/2026 4:22:16 PM EST |